Provider review
Vital Edge review
Every price loads from a backend invisible to any static check
No price exists in anything a static check can read — every figure loads from a backend at runtime. Our last check recorded semaglutide at $350 a month and tirzepatide at $450, with oral capsules from $199, none of which we could reconfirm.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
Vital Edge's menu is broader than most competitors — both compounded and brand-name options across injectable and oral forms. But every price on the site loads from a backend invisible to any automated check, meaning a reader can't compare costs without running the full intake flow directly. Confirm actual pricing before assuming any previously-recorded figure still applies.
Vital Edge is not ranked on any of our rankings. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You want a broad menu spanning compounded and brand-name GLP-1s, injectable and oral
- You want a provider that displays a LegitScript certification
- You're comfortable running the full intake flow to see your actual price, since nothing is published statically
Look elsewhere if
- You want to compare pricing before starting an intake — no figure is visible anywhere without running the live site
- You want a named compounding pharmacy or medical director — neither was found
- You want to read the refund policy before enrolling — it returned no usable content
What it actually costs
What they advertise
Pricing not published in any statically checkable form — loads from a backend at runtime.
What you actually pay, month to month
Pricing not published; prior, not-independently-reconfirmed research recorded $350/mo semaglutide and $450/mo tirzepatide.
We checked Vital Edge's own public pages in August 2026 and found no dollar figure. We do not print a number we cannot see, and we do not repeat one from a third-party blog. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what Vital Edge bundles in, and what it does not.
Clinician consult
Physician-supervised video visit.
Bloodwork / labs
Not published.
Follow-ups and dose changes
No cadence published.
Human support
Not published.
Injection supplies
Not published.
Shipping
Monthly shipment to your door, at our last check.
Pharmacy, labs and oversight
The pharmacy
Not named in any source we could reach.
Oversight
No cadence published.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
All 50 states, with TN, GA, AL, NC, SC, FL, and KY specifically highlighted.
The honest cons
The part they would rather you skipped
Vital Edge's pricing loads entirely from a backend service at runtime — no dollar figure for any product appears anywhere in the site's static code, meaning a reader cannot compare costs against competitors without running the full live intake flow themselves.
- No pricing published in any statically checkable form
- No compounding pharmacy or medical director named
- Refund/terms page returned no usable content
- State-by-state coverage details beyond the highlighted states aren't fully enumerated
None of this is unique to Vital Edge — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are cataloged in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that ranking ranks them. Vital Edge is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- COCollectiveThe cheapest medication price here, on a membership the headline omits
- CoreAge RxOne price that does not move when your dose does
- BHBodybuilding Health+The deep peptide catalog is gone; the GLP-1 pricing got better
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- Found HealthInsurance-integrated, unlike every cash-only compounder here — but $99 needs a prepay
- Direct MedsThe plainest price mechanics on either ranking, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
13 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect Vital Edge's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Vital Edge's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.